Literature DB >> 2446633

Inhibition of HIV reverse transcriptase by 2',3'-dideoxynucleoside triphosphates.

M S Chen1, S C Oshana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2446633     DOI： 10.1016/0006-2952(87)90685-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.

Authors:  S W Mamber; K W Brookshire; S Forenza
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Kinetics and inhibition of reverse transcriptase from human and simian immunodeficiency viruses.

Authors:  J C Wu; M Chernow; R E Boehme; R T Suttmann; M J McRoberts; E J Prisbe; T R Matthews; P A Marx; R Y Chuang; M S Chen
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome.

Authors:  T W North; G L North; N C Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 4.  Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?

Authors:  G Moyle
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

5.  Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency viruses.

Authors:  T W North; R C Cronn; K M Remington; R T Tandberg
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus.

Authors:  M M Mansuri; M J Hitchcock; R A Buroker; C L Bregman; I Ghazzouli; J V Desiderio; J E Starrett; R Z Sterzycki; J C Martin
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

7.  Single dose and multiple dose pharmacokinetics of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine, anti-HIV agents, in rats.

Authors:  N R Srinivas; W C Shyu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.441

8.  3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.

Authors:  R W Buckheit; J Germany-Decker; K Qualls-Goodwin; B J Bowdon; W M Shannon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 9.  Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Authors:  R Whittington; R N Brogden
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

10.  Pharmacokinetics of 2',3'-dideoxyinosine in monkeys.

Authors:  M X Qian; T S Finco; A R Swagler; J M Gallo
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.